| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Dipartimento di Patologia e Medicina Sperimentale e Clinica, and Dipartimento di Scienze e Tecnologie Biomediche, Sezione di Genetica (R.L., D.F., G.D.), Università degli Studi di Udine, 33100 Udine, Italy
Address all correspondence and requests for reprints to: Dr. Renata Lonigro, Dipartimento di Scienze e Tecnologie Biomediche, Sezione di Genetica, Università degli Studi di Udine, P. le M. Kolbe 4, 33100 Udine, Italy. E-mail: rlonigro{at}makek.dstb.uniud.it
Alteration of the redox potential has been proposed as a mechanism
influencing gene expression. Reduced glutathione (GSH) is one of the
cellular scavengers involved in the regulation of the redox potential.
To test the role that GSH may play in thyroid cells, we cultured a
differentiated rat thyroid cell strain (FRTL-5) in the presence of
L-buthionine-(S,R)-sulfoximine (BSO). BSO
affects GSH synthesis by irreversibly inhibiting
-glutamylcysteine
synthetase (EC 6.3.2.2), a specific enzyme involved in GSH synthesis.
BSO-treated FRTL-5 cells show a great decrease in the GSH level,
whereas malondialdehyde increases in the cell culture medium as a sign
of lipid peroxidation. In these conditions the activity of two
thyroid-specific promoters, thyroglobulin (Tg) and thyroperoxidase
(TPO), is strongly reduced in transient transfection experiments. As
both Tg and TPO promoters depend upon the thyroid-specific
transcription factors, thyroid-specific transcription factor-1 (TTF-1)
and Pax-8 for full transcriptional activity, we tested whether
reduction of GSH concentration impairs the activity of these
transcription factors. After BSO treatment of FRTL-5 cells, both
transcription factors fail to trans-activate the
respective chimerical targets, C5 and B-cell specific activating
protein promoters, containing, respectively, multimerized TTF-1-
or Pax-8-binding sites only as well as the Tg and TPO natural
promoters. Northern analysis revealed that endogenous Tg messenger RNA
(mRNA) expression is also reduced by BSO treatment, whereas endogenous
TPO expression is not modified. Furthermore, the Pax-8 mRNA steady
state concentration does not change in BSO-treated cells, whereas TTF-1
mRNA slightly decreases. Immunoblotting analysis of FRTL-5 nuclear
extracts does not show significant modification of the Pax-8
concentration in BSO-treated cells, whereas a decrease of 25% in TTF-1
protein is revealed. Furthermore, BSO treatment decreases the
DNA-binding activity to the respective consensus sequence of both
transcription factors. Finally, different mechanisms seem to act on
TTF-1 and Pax-8 functional impairment in BSO-treated cells. Indeed,
with a lowered GSH concentration, the overexpressed Pax-8 still
activates transcription efficiently, whereas, on the contrary, the
overexpressed TTF-1 does not recover its
trans-activation capability when the respective
chimerical target sequences are used (C5 and BSAP). When the
natural Tg and TPO promoter sequences are used, overexpression of Pax-8
parallels the effect on both promoters observed using the chimeric
target sequences, whereas overexpression of TTF-1 increases TPO
promoter transcriptional activity only.
This article has been cited by other articles:
![]() |
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cao, F. Kambe, X. Lu, N. Kobayashi, S. Ohmori, and H. Seo Glutathionylation of Two Cysteine Residues in Paired Domain Regulates DNA Binding Activity of Pax-8 J. Biol. Chem., July 8, 2005; 280(27): 25901 - 25906. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |